Drug Trial Radar · NCT04774237
Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Last checked: Nov 20, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Mar 24, 2021
Primary completion
Oct 19, 2021
Study completion Oct 19, 2021
Sponsor
- Lead sponsor
- Visus TherapeuticsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia
Conditions
- Presbyopia
Interventions
BRIMOCHOL™Drug
A single drop in each eye at a visit.
BRIMOCHOL™ FDrug
A single drop in each eye at a visit.
CarbacholDrug
A single drop in each eye at a visit.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects With a >=15 Letter Gain Without a < 5 Letter Loss in Near Visual AcuityTime frame: Day 1, Hour 1 post-dose
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Global Research Management, Inc.
Glendale, California
Eye Research Foundation
Newport Beach, California
Total Eye Care, PA
Memphis, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.